Safety and feasibility of biweekly neoadjuvant gemcitabine, epirubicin, and albumin bound nab-paclitaxel (GEA) in locally advanced breast cancer – results of a phase II study
D. Daniel, B. Daniel, R. Inhorn, Y. Naot, J. Zubkus, L. Simons, D. Knauer, V. Trieu, N. Desai, D. YardleyVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70557-3
File:
PDF, 74 KB
english, 2008